Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib
Clinical trial NCT06531109 · RECRUITING
Trial details
- NCT number
- NCT06531109
- Sponsor
- Pfizer
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-08-07
- Primary completion
- 2028-04-15
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.